PlainRecalls
FDA Drug Moderate Class II Terminated

Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04

Reported: September 27, 2017 Initiated: August 22, 2017 #D-1168-2017

Product Description

Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04

Reason for Recall

Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Details

Recalling Firm
Pfizer Inc.
Units Affected
98,050 vials
Distribution
United States Nationwide (including Puerto Rico) and Singapore
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04. Recalled by Pfizer Inc.. Units affected: 98,050 vials.
Why was this product recalled?
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 27, 2017. Severity: Moderate. Recall number: D-1168-2017.